Kymera Therapeutics KYMR
NASDAQ KYMR
$110.51 -1.49 (-1.33%)
At close: Sep 29, 2026 · 4:00 PM EDT

Kymera Therapeutics (KYMR) Total Current Liabilities (2019 - 2026)

Updated

Kymera Therapeutics (KYMR) reported Total Current Liabilities of $71.33 million for Q2 2026, down 18.5% from $87.54 million a year earlier but up 13.9% from the prior quarter.

Analysis

Kymera Therapeutics (KYMR) Total Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Kymera Therapeutics posted Total Current Liabilities of $83.21 million, up 22.8% from FY2024.

  • Total Current Liabilities has a five-year compound annual growth rate of -5.5% (FY2020 to FY2025).
  • By year, Total Current Liabilities came in at $67.77 million in FY2024 (-20.9%), $85.69 million in FY2023 (+20.1%), $71.34 million in FY2022 (-22.9%) and $92.54 million in FY2021 (-16.3%).
  • Five-year quarterly Total Current Liabilities spans a low of $54.6 million in Q2 2023 and a high of $94.49 million in Q3 2021.
  • Year over year, Total Current Liabilities gained in six of the last eight quarters, with growth averaging 6.1%.
  • The high point for year-over-year Total Current Liabilities in five years was Q2 2025 (growth of 40.9%); the low point was Q2 2023 (a decline of 37.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $62.64 million (Q1 2026), $83.21 million (Q4 2025) and $71.58 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Kymera Therapeutics 9.27 Bn 6.58 Bn - 71.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 71.33 Mn
Mar 31, 2026 62.64 Mn
Dec 31, 2025 83.21 Mn
Sep 30, 2025 71.58 Mn
Jun 30, 2025 87.54 Mn
Mar 31, 2025 58.99 Mn
Dec 31, 2024 67.77 Mn
Sep 30, 2024 66.53 Mn
Jun 30, 2024 62.14 Mn
Mar 31, 2024 56.14 Mn
Dec 31, 2023 85.69 Mn
Sep 30, 2023 63.17 Mn
Jun 30, 2023 54.60 Mn
Mar 31, 2023 61.93 Mn
Dec 31, 2022 71.34 Mn
Sep 30, 2022 91.12 Mn
Jun 30, 2022 87.50 Mn
Mar 31, 2022 88.34 Mn
Dec 31, 2021 92.54 Mn
Sep 30, 2021 94.49 Mn
API Access

Kymera Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=KYMR&period=max&api_key=YOUR_API_KEY